Home sanofi
 

Keywords :   


Tag: sanofi

Sanofi Pasteur and Merck (Known as MSD Outside the United States and Canada) Announce Intent to End Joint Vaccines Operations in Europe, Sanofi Pasteur MSD, to Pursue Their Own Distinct Growth Strategies

2016-03-08 14:00:00| Merck.com - Corporate News

Dateline City: KENILWORTH, N.J. & LYON, France KENILWORTH, N.J. & LYON, France--(BUSINESS WIRE)--Sanofi Pasteur and Merck, known as MSD outside the United States and Canada, today announced their intent to end their joint vaccines operations in Europe. Upon concluding their joint venture, both companies plan to integrate their respective European vaccine businesses into their operations, independently manage their product portfolios and pursue their own distinct growth strategies in Europe. Language: English Contact: MerckMedia:Lainie Keller, 908-236-5036orInvestor:Justin Holko, 908-740-1879orSanofi PasteurMedia:Alain Bernal, +33 4 37 37 50 38orInvestor:Sébastien Martel, +33 1 53 77 45 45 Ticker Slug: Ticker: MRK Exchange: NYSE Ticker: SAN Exchange: BOURSE Ticker: SNY Exchange: NYSE read more

Tags: to their end own

 

Sanofi SA (SNY) Receives "Neutral" Rating from Bryan Garnier & Cie

2016-01-02 18:17:28| Biotech - Topix.net

's stock had its "neutral" rating reaffirmed by equities researchers at Bryan Garnier & Cie in a research report issued on Monday, AnalystRatings.Net reports. Sanofi SA opened at 42.65 on Monday.

Tags: rating receives neutral bryan

 
 

Boehringer Ingelheim, Sanofi enter negotiations on business swap

2015-12-15 06:00:00| National Hog Farmer

Sanofi and Boehringer Ingelheim today announced that the companies have entered into exclusive negotiations to swap businesses — an exchange of Sanofi animal health business (Merial) and the BI consumer healthcare business. Merial has an enterprise value of 11.4 billion euros and the BI consumer healthcare business has an enterprise value of 6.7 billion euros. BI CHC business in China would be excluded from the transaction. The transaction would also include a gross cash payment from BI to Sanofi of 4.7 billion euros. read more

Tags: business enter negotiations swap

 

BNP Paribas Lowers Sanofi SA (SNY) to Underperform

2015-12-13 00:03:11| Biotech - Topix.net

SNY has been the topic of a number of other research reports. Morgan Stanley raised shares of Sanofi SA from an "equal weight" rating to an "overweight" rating in a research report on Thursday, October 15th.

Tags: lowers bnp sanofi paribas

 

Sanofi settles lawsuit enabling rival to Lantus insulin

2015-09-28 21:37:27| Biotech - Topix.net

This product image provided by Sanofi shows Lantus SoloStar, the French drugmaker's once-daily insulin in a pen-like injector. Sanofi on Monday, Sept.

Tags: enabling rival lawsuit insulin

 

Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] next »